We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Rebuffs Teva’s Citizen Petition on Generic Copaxone Filings
FDA Rebuffs Teva’s Citizen Petition on Generic Copaxone Filings
March 31, 2009
The FDA has declined to review a citizen petition submitted by Teva Neurosciences asking the agency not to accept applications for generic versions of the Copaxone multiple sclerosis (MS) treatment until certain conditions are met.